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We describe a case of pulmonary alveolar 
proteinosis (PAP) treated with whole  lung lavage
(WLL) using venoarterial ECMO for 
cardiopulmonary support rather than  the 
conventional venovenous support and describe 
why this method was advantageous.
Objective
Conclusions
Venoarterial extracorporeal membrane oxygenation (ECMO) for support during 
whole lung lavage for pulmonary alveolar proteinosis.
Julie Monteagudo, MD1; Nicholas Cavarocchi, MD1; Boyd Hehn, MD2; Naveed Hasan,MD2;  Hitoshi Hirose, MD, PhD1
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Background
• Whole lung lavage is the standard treatment for 
progressive PAP leading to respiratory 
compromise
•Venovenous support has been described in the 
literature, venoarterial support is only used rarely
Post Operative Course
• We propose that VA ECMO is superior to VV 
ECMO during whole lung lavage for the following 
reasons:
•Hemodynamic support removes the strain on the 
right ventricle during the stress of WLL
•Avoids hypoxemia during WLL and post 
operatively
•Allows safety during repositioning of patient 
during WLL to allow percussion and patient turns
•Allows for bilateral lavage rather than staggered 
unilateral lavage
•VA ECMO allows hemodynamic and pulmonary 
support during WLL for PAP
Case Presentation
•44 year old female with Bechet’s disease, BMI 37
•Presents with progressive dyspnea, undergoes 
CT scan, suspicious for PAP
•Respiratory compromise prompts VATS biopsy 
for definitive diagnosis, PAP found on biopsy
•Pt required intubation, difficult to oxygenate, 
taken to operating room  emergently for VA 
ECMO and WLL
•Right femoral cannulation with 20F venous cannula
and 18F arterial cannula
•Retrograde arterial cannula used to preserve distal 
limb perfusion
•ECMO flows obtained were satisfactory at 4L/min
•WLL subsequently performed using 12 liters in one 
liter instillations with chest physiotherapy between 
liters
•Appearance of fluid initially serosanguineous and 
turbid and ultimately became serous and transparent 
Operative Details
Case Presentation
•Decannulated from ECMO on POD#5 with 
dramatic improvement in oxygenation
•PAP thought to be secondary to Bechet’s
disease, no anti- GM CSF antibodies to allow 
treatment with Sargramostim
•Pt discharged from the hospital doing well in 
follow up
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